Literature DB >> 4840450

Disk susceptibility studies with cefazolin and cephalothin.

P Actor, J Guarini, J Uri, J Dickson, J F Pauls, J A Weisbach.   

Abstract

Cefazolin and cephalothin disk susceptibility and minimal inhibitory concentration determinations were conducted on 591 clinical isolates. Cefazolin demonstrated superior activity, as shown by lower minimal inhibitory concentrations, and a greater percentage of isolates inhibited in the disk susceptibility test. The cephalothin antibiotic class disk by the standard Bauer-Kirby method failed to detect susceptibility to cefazolin in a significant percentage of Escherchia coli, Enterobacter species, and Enterococcus isolates. A separate cefazolin disk with a susceptibility cut-off point of 18 mm is recommended. An alternative to a separate cefazolin disk would be a reinterpretation of the cephalothin susceptibility disk zone diameters so that it would more adequately predict cefazolin activity.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4840450      PMCID: PMC428919          DOI: 10.1128/AAC.5.1.63

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  9 in total

1.  Laboratory and clinical studies on cefazolin, a new derivative of semisynthetic cephalosporin.

Authors:  K Seiga; K Yamaji; K Miyoshi; M Minagawa
Journal:  Int J Clin Pharmacol       Date:  1972-06

2.  Clinical laboratory study of cephacetrile and cephalothin against bacteria recently isolated from clinical specimens.

Authors:  H D Isenberg; B G Painter; J Sampson-Scherer; M Siegel
Journal:  Am J Clin Pathol       Date:  1973-05       Impact factor: 2.493

3.  Clinical studies of cefazolin in the surgical field.

Authors:  K Shibata; M Fujii
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1970

4.  In vitro and in vivo evaluation of cefazolin, a new cephalosporin C derivative.

Authors:  M Nishida; T Matsubara; T Murakawa; Y Mine; Y Yokota; S Kuwahara; S Goto
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1969

5.  Evaluation of the Bauer-Kirby-Sherris-Turck single-disc diffusion method of antibiotic susceptibility testing.

Authors:  J M Matsen; M J Koepcke; P G Quie
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1969

6.  Antibiotic susceptibility testing by a standardized single disk method.

Authors:  A W Bauer; W M Kirby; J C Sherris; M Turck
Journal:  Am J Clin Pathol       Date:  1966-04       Impact factor: 2.493

7.  Biological properties of three 3-heterocyclic-thiomethyl cephalosporin antibiotics.

Authors:  W E Wick; D A Preston
Journal:  Antimicrob Agents Chemother       Date:  1972-03       Impact factor: 5.191

8.  Clinical and in vitro evaluation of cefazolin, a new cephalosporin antibiotic.

Authors:  K Ries; M E Levison; D Kaye
Journal:  Antimicrob Agents Chemother       Date:  1973-02       Impact factor: 5.191

9.  Evaluation of cefazolin, a new cephalosporin antibiotic.

Authors:  L B Reller; W W Karney; H N Beaty; K K Holmes; M Turck
Journal:  Antimicrob Agents Chemother       Date:  1973-04       Impact factor: 5.191

  9 in total
  3 in total

1.  Diffusion disk susceptibility testing with cefaclor.

Authors:  S Shadomy; M Carver
Journal:  Antimicrob Agents Chemother       Date:  1978-02       Impact factor: 5.191

2.  SK&F 75073, new parenteral broad-spectrum cephalosporin with high and prolonged serum levels.

Authors:  P Actor; J V Uri; I Zajac; J R Guarini; L Phillips; D H Pitkin; D A Berges; G L Dunn; J R Hoover; J A Weisbach
Journal:  Antimicrob Agents Chemother       Date:  1978-05       Impact factor: 5.191

3.  Antibiotic resistance patterns of outpatient pediatric urinary tract infections.

Authors:  Rachel S Edlin; Daniel J Shapiro; Adam L Hersh; Hillary L Copp
Journal:  J Urol       Date:  2013-01-28       Impact factor: 7.450

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.